Patent Assignment
Reel/Frame 074489/0176
Change of Name
Recorded: 2026-01-26
Pages: 6
Assignor
MIND MEDICINE, INC.
Executed: 2026-01-08
Assignee
DEFINIUM THERAPEUTICS US, INC.
ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NEW YORK, 10007
Covered Properties
(67)
System and Method for Patient Monitoring of Gastrointestinal Function Using Automated Stool Classifications
Application:
62/860,656 →
18-Mc for Treatment of Substance Use Disorders
Application:
62/908,754 →
Mescaline Derivatives with Modified Action
Application:
63/153,317 →
Formulations of Psilocin That Have Enhanced Stability
Application:
63/157,682 →
Psychedelics for Treatment of Pain
Application:
63/183,578 →
Method of Titrating Dose of Psychedelics
Application:
63/183,579 →
Movement Disorders
Application:
63/183,771 →
Liposome Delivery of Psychedelics
Application:
63/184,000 →
Formulations of Psilocin That Have Enhanced Stability
Application:
63/184,691 →
Mdma Enantiomers
Application:
63/184,703 →
Controlling Effects After 5HT2A Agonists Administration
Application:
63/210,346 →
18-Mc for Treating Obesity
Application:
63/216,118 →
System and Method for Monitoring a Consciousness-Altering Therapeutic Session
Application:
63/216,683 →
System and Method for Automatic Analysis of Texts in Psychotherapy, Counseling, and Other Mental Health Management Activities
Application:
63/234,336 →
Immediate Release Formulations of D-Lysergic Acid Diethylamide for Therapeutic Applications
Application:
63/234,773 →
Desoxyscaline Derivatives with Modified Mescaline-Like Action
Application:
63/280,439 →
18-Mc Salt Forms
Application:
63/317,632 →
Lysergic Acid Derivatives with Modified Lsd-Like Action
Application:
63/353,673 →
R-Mdma Crystal Forms
Application:
63/355,576 →
4-Alkenyl and 4-Alkynyl Phenethylamine Derivatives and Related Compounds with Modified Dom-Like Action
Application:
63/429,101 →
R-Mdma for Treatment of Pain
Application:
63/487,370 →
Allyl- and Propargylamine-Type Phenethylamines and Tryptamines for Substance-Assisted Psychotherapy
Application:
63/509,597 →
Methods of Treating Generalized Anxiety Disorder
Application:
63/608,396 →
Formulations of Psychedelics for Improving Pharmacokinetic Properties
Application:
63/608,486 →
18-Mc for Treatment of Substance Use Disorders
Mescaline Derivatives with Modified Action
Application:
17/676,169 →
Publication:
US 2022/0267252
Formulations of Psilocin That Have Enhanced Stability
Application:
17/687,568 →
Publication:
US 2022/0280482
Psychedelics for Treatment of Pain
Application:
17/732,878 →
Publication:
US 2022/0347195
Liposome Delivery of Psychedelics
Application:
17/733,389 →
Publication:
US 2022/0354862
Method of Titrating Dose of Psychedelics
Application:
17/734,098 →
Publication:
US 2023/0346645
Mdma Enantiomers
Application:
17/734,100 →
Publication:
US 2022/0354822
Movement Disorders
Controlling Effects After 5HT2A Agonists Administration
Application:
17/833,829 →
Publication:
US 2022/0395499
18-Mc for Treating Obesity
Application:
17/835,051 →
Publication:
US 2022/0409628
System and Method for Monitoring a Consciousness-Altering Therapeutic Session
Application:
17/839,374 →
Publication:
US 2023/0000431
Psychedelics for Treatment of Pain
Application:
17/877,521 →
Publication:
US 2022/0362237
Formulations of Psilocin That Have Enhanced Stability
Application:
17/883,509 →
Publication:
US 2022/0370413
System and Method for Automatic Analysis of Texts in Psychotherapy, Counseling, and Other Mental Health Management Activities
Application:
17/889,415 →
Publication:
US 2023/0053429
Immediate Release Formulations of D-Lysergic Acid Diethylamide for Therapeutic Applications
Immediate Release Formulations of D-Lysergic Acid Diethylamide for Therapeutic Applications
Application:
17/890,198 →
Publication:
US 2023/0064429
Desoxyscaline Derivatives with Modified Mescaline-Like Action
Application:
17/987,922 →
Publication:
US 2023/0150906
Mescaline Derivatives with Modified Action
Application:
18/070,374 →
Publication:
US 2023/0091369
Lyophilized Orally Disintegrating Tablet Formulations of D-Lysergic Acid Diethylamide for Therapeutic Applications
Immediate Release Formulations of D-Lysergic Acid Diethylamide for Therapeutic Applications
Application:
18/077,096 →
Publication:
US 2023/0107398
18-Mc for Treatment of Substance Use Disorders
Application:
18/174,063 →
Publication:
US 2023/0201217
18-Mc Salt Forms
Application:
18/177,073 →
Publication:
US 2023/0303572
Mdma Enantiomers
Application:
18/186,494 →
Publication:
US 2023/0226019
Mdma Enantiomers
Application:
18/186,764 →
Publication:
US 2023/0226020
Mescaline Derivatives with Modified Action
Application:
18/190,407 →
Publication:
US 2023/0227398
Lyophilized Orally Disintegrating Tablet Formulations of D-Lysergic Acid Diethylamide for Therapeutic Applications
Desoxyscaline Derivatives with Modified Mescaline-Like Action
Application:
18/196,992 →
Publication:
US 2023/0285327
Movement Disorders
Application:
18/197,892 →
Publication:
US 2023/0301985
IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS
Application:
18/199,244 →
Publication:
US 2023/0285386
R-Mdma Crystal Forms
Application:
18/325,655 →
Publication:
US 2023/0416219
Formulations of Psilocin That Have Enhanced Stability
Mdma Enantiomers
Application:
18/331,682 →
Publication:
US 2023/0310368
Lysergic Acid Derivatives with Modified Lsd-Like Action
Application:
18/337,253 →
Publication:
US 2023/0414583
R-Mdma for Treatment of Pain
Application:
18/421,264 →
Publication:
US 2024/0285576
4-Alkenyl and 4-Alkynyl Phenethylamine Derivatives and Related Compounds with Modified Dom-Like Action
Application:
18/493,385 →
Publication:
US 2024/0174594
R-Mdma Crystal Forms
Application:
18/611,400 →
Publication:
US 2025/0019359
Allyl-And Propargylamine-Type Phenethylamines and Tryptamines for Treating Medical Disorders
Application:
18/750,991 →
Publication:
US 2025/0312309
Formulations of Psilocin That Have Enhanced Stability
Application:
18/824,317 →
Publication:
US 2025/0205196
Formulations of Psilocin That Have Enhanced Stability
Application:
19/023,120 →
Publication:
US 2025/0161267
Formulations of Psilocin That Have Enhanced Stability
Application:
19/023,132 →
Publication:
US 2025/0161268
Lyophilized Orally Disintegrating Tablet Formulations of D-Lysergic Acid Diethylamide for Therapeutic Applications
Application:
19/276,575 →
Publication:
US 2025/0345323
System and Method for Patient Monitoring of Gastrointestinal Function Using Automated Stool Classifications
Methods of Treating Generalized Anxiety Disorder
PCT:
PCT/US2024/059413 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 25, 2019
From: KARLIN, DAN R; DUBEC, PETER; MAJERNIK, MARTIN; BOZA, VLADO
To: HEALTHMODE, INC.
Reel/Frame 049581/0013 →
Assignment of Assignor's Interest
Mar 31, 2021
From: FREEMAN, SCOTT; REELE, STOTS B.; BONELLE, JEANNE
To: MIND MEDICINE INC.
Reel/Frame 055789/0347 →
Assignment of Assignor's Interest
Apr 8, 2021
From: BARROW, ROBERT
To: MIND MEDICINE, INC.
Reel/Frame 055859/0614 →
Assignment of Assignor's Interest
May 12, 2021
From: BARROW, ROBERT
To: MIND MEDICINE, INC.
Reel/Frame 056214/0666 →
Assignment of Assignor's Interest
May 14, 2021
From: BARROW, ROBERT; KARLIN, DANIEL R.
To: MIND MEDICINE, INC.
Reel/Frame 056238/0643 →
Assignment of Assignor's Interest
May 14, 2021
From: BARROW, ROBERT
To: MIND MEDICINE, INC.
Reel/Frame 056238/0589 →
Assignment of Assignor's Interest
May 14, 2021
From: BARROW, ROBERT; KARLIN, DANIEL R.
To: MIND MEDICINE, INC.
Reel/Frame 056238/0752 →
Assignment of Assignor's Interest
May 21, 2021
From: BARROW, ROBERT; KARLIN, DANIEL R.
To: MIND MEDICINE, INC.
Reel/Frame 056319/0257 →
Assignment of Assignor's Interest
May 21, 2021
From: BARROW, ROBERT; KARLIN, DANIEL R.
To: MIND MEDICINE, INC.
Reel/Frame 056319/0221 →
Assignment of Assignor's Interest
Jun 24, 2021
From: KARLIN, DANIEL R.; BARROW, ROBERT
To: MIND MEDICINE, INC.
Reel/Frame 056645/0867 →
Assignment of Assignor's Interest
Jun 29, 2021
From: BARROW, ROBERT; KARLIN, DANIEL R.
To: MIND MEDICINE, INC.
Reel/Frame 056703/0571 →
Assignment of Assignor's Interest
Jul 16, 2021
From: MAJERNIK, MARTIN; KARLIN, DANIEL R.; BARROW, ROBERT; DUBEC, PETER
To: MIND MEDICINE, INC.
Reel/Frame 056889/0460 →
Assignment of Assignor's Interest
Aug 29, 2021
From: KOLAR, ADAM; MAJERNIK, MARTIN; DOS SANTOS PINHEIRO, MIGUEL AMAVEL; KARLIN, DANIEL R.
To: MIND MEDICINE, INC.
Reel/Frame 057320/0600 →
Assignment of Assignor's Interest
Sep 3, 2021
From: MACK, PETER; WERNLI, MIRI HALPERIN; BARROW, ROBERT; SCHROEDER, JON
To: MIND MEDICINE, INC.
Reel/Frame 057380/0608 →
Assignment of Assignor's Interest
Sep 17, 2021
From: HEALTHMODE, INC.
To: MIND MEDICINE, INC.
Reel/Frame 057511/0516 →
Assignment of Assignor's Interest
Dec 9, 2021
From: LIECHTI, MATTHIAS EMANUEL; LUSTENBERGER, FELIX; TRACHSEL, DANIEL
To: MIND MEDICINE, INC.
Reel/Frame 058342/0914 →
Assignment of Assignor's Interest
Dec 13, 2021
From: LIECHTI, MATTHIAS EMANUEL; LUSTENBERGER, FELIX; TRACHSEL, DANIEL
To: MIND MEDICINE, INC.
Reel/Frame 058367/0675 →
Assignment of Assignor's Interest
Feb 20, 2022
From: TRACHSEL, DANIEL; LIECHTI, MATTHIAS EMANUEL; LUSTENBERGER, FELIX
To: MIND MEDICINE, INC.
Reel/Frame 059054/0594 →
Assignment of Assignor's Interest
Apr 1, 2022
From: BONELLE, JEANNE; LEVY, DANIEL EMIL; NEWMAN, ANN; SCHNEIDER, STEPHEN E.
To: MIND MEDICINE, INC.
Reel/Frame 059470/0935 →
Assignment of Assignor's Interest
May 4, 2022
From: BARROW, ROBERT; KARLIN, DANIEL R.
To: MIND MEDICINE, INC.
Reel/Frame 059807/0807 →
Assignment of Assignor's Interest
May 4, 2022
From: BARROW, ROBERT; KARLIN, DANIEL R.
To: MIND MEDICINE, INC.
Reel/Frame 059808/0290 →
Assignment of Assignor's Interest
May 5, 2022
From: BARROW, ROBERT; KARLIN, DANIEL R.
To: MIND MEDICINE, INC.
Reel/Frame 059826/0098 →
Assignment of Assignor's Interest
May 6, 2022
From: BARROW, ROBERT; KARLIN, DANIEL R.
To: MIND MEDICINE, INC.
Reel/Frame 059837/0743 →
Assignment of Assignor's Interest
Jun 14, 2022
From: KARLIN, DANIEL R.; BARROW, ROBERT
To: MIND MEDICINE, INC.
Reel/Frame 060198/0778 →
Assignment of Assignor's Interest
Jun 15, 2022
From: MAJERNIK, MARTIN; KARLIN, DANIEL R.; BARROW, ROBERT; DUBEC, PETER
To: MIND MEDICINE, INC.
Reel/Frame 060216/0821 →